Do peptide scalp serums actually grow hair, or just good marketing?

What's this video probably claiming?

The OGX ProGrowth + Peptide Scalp Serum video is almost certainly leaning hard on two words: peptides and growth. The caption's phrasing, "packed with peptides for an effective hair growth routine," implies that the peptide content is the active mechanism driving regrowth. The applicator design gets framed as a delivery innovation, making the serum sound clinical. This is a classic consumer beauty move: borrow the language of peptide science, the same science behind compounds like GHK-Cu that have real dermatological research behind them, and apply it to an OTC cosmetic where the concentrations, formulations, and regulatory standards are completely different. The implicit promise here is that you can buy meaningful hair growth at a Walmart price point. That claim deserves a hard look.

What does the science actually show?

GHK-Cu (copper tripeptide-1) is probably the most studied peptide in the hair growth space. Pickart et al. (2015, Journal of Aging Science) documented GHK-Cu's role in stimulating dermal papilla cells and increasing follicle size in animal models. A small 2018 study published in the Annals of Dermatology by Lim et al. found that a 3% copper peptide solution applied daily for 16 weeks produced modest but measurable improvements in hair density in patients with androgenetic alopecia. The operative word there is 3%, applied for 16 consecutive weeks, in a controlled clinical setting. Cosmetic serums sold at mass retail are not required to disclose active concentrations, and "packed with peptides" tells us nothing about whether the dose is anywhere near therapeutically relevant. Minoxidil, the actual FDA-approved topical standard of care, works at defined concentrations (2% and 5%) that have been validated across multiple RCTs.

Where does the social media noise diverge from clinical reality?

TikTok hair content has a specific problem: before-and-after results are almost always confounded by lighting, camera angle, and the simple fact that hair growth is highly seasonal and cyclical. A video showing "results" from a peptide serum over 8 weeks cannot control for any of that. Beyond visuals, the peptide category itself is being stretched here. The bioactive peptides with actual clinical trial backing, GHK-Cu, PTD-DBM analogs, and bimatoprost-derived compounds, require specific pH environments, penetration enhancers, and concentrations to reach the dermal papilla at all. Most cosmetic serums sit on the skin surface. A 2021 review in the International Journal of Molecular Sciences (Stevenson et al.) noted that topical peptide bioavailability remains a significant barrier and that most cosmetic claims outpace the delivery science. An applicator that clicks and massages does not solve that barrier.

What should you actually know?

If you are actually concerned about hair thinning, the evidence hierarchy is clear. Minoxidil has the strongest OTC evidence base. Finasteride (oral) has the strongest prescription evidence for androgenetic alopecia in men, though it carries documented side effects worth discussing with a clinician. Low-level laser therapy has emerging RCT support. Peptide-based topicals are genuinely interesting science, and GHK-Cu in particular has enough mechanistic data to warrant continued research, but a mass-market serum at a retailer is not a clinical-grade intervention. If a creator or brand implies their peptide serum is an effective replacement for proven treatments, that is not supported by the current literature. Use it as an adjunct if you like the product, but do not let marketing language substitute for a real conversation with a dermatologist about what is actually happening at your follicle level.